NCT00779376View on ClinicalTrials.gov

Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions

NACompletedINTERVENTIONAL
Enrollment

68

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

March 31, 2005

Study Completion Date

April 30, 2005

Conditions
Healthy
Interventions
DRUG

Zidovudine 300mg tablets

Trial Locations (1)

H4R2N6

MDS Pharma Services, Montreal

All Listed Sponsors
lead

Ranbaxy Laboratories Limited

INDUSTRY

NCT00779376 - Bioequivalence Study of Zidovudine 300 mg Tablets, USP Under Fed Conditions | Biotech Hunter | Biotech Hunter